A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma

by Horimi Tadashi, Morita Sojiro, Tsuji Akihito, Kobayashi Kazuma, Shirasaka Tetsuhiko, Kanematsu Takashi
Published 2006-05-01